{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T19:33:15Z","timestamp":1782588795338,"version":"3.54.5"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disorder characterized by the destruction of insulin-producing beta cells in the pancreas, necessitating lifelong insulin therapy. Despite advancements in glucose monitoring and insulin delivery, current treatments remain palliative and fail to address the root autoimmune pathology or restore endogenous insulin production. Stem cell therapy has emerged as a promising curative approach due to its dual capacity to regenerate beta cells and modulate immune responses by suppressing autoreactive immune cells and promoting immune tolerance. This review explores the various types of stem cells under investigation \u2013 embryonic stem cells, induced pluripotent stem cells, mesenchymal stem cells, and pancreatic progenitor cells \u2013 highlighting their unique advantages and limitations. We delve into mechanisms of action including cell differentiation protocols, immune protection strategies such as encapsulation, and the synergistic use of gene editing to enhance graft survival. Recent preclinical successes and early-phase clinical trials have demonstrated partial insulin independence in up to 40% of participants, with others showing 20\u201330% reductions in exogenous insulin requirements and measurable increases in C-peptide levels sustained for 6\u201312\u00a0months. However, challenges remain in achieving scalable production, long-term engraftment, and immune tolerance. As research continues to overcome these barriers, stem cell therapy holds transformative potential to shift T1DM treatment from management to functional cure.<\/jats:p>","DOI":"10.1097\/ms9.0000000000004147","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T13:01:45Z","timestamp":1763730105000},"page":"8556-8562","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Stem cell therapy: a paradigm shift in reversing type 1 diabetes mellitus"],"prefix":"10.1097","volume":"87","author":[{"given":"Afraah Mohammed","family":"Mouzzam","sequence":"first","affiliation":[{"name":"Department of Medicine, Ayaan Institute Of Medical Sciences, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisa","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Medicine, NCA - Fairfield General Hospital, Bury, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliza","family":"Aamir","sequence":"additional","affiliation":[{"name":"Department of Medicine, Liaquat University of Medical Health and Sciences, Jamshoro, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Sharma","sequence":"additional","affiliation":[{"name":"Mahatma Gandhi Medical College, Jaipur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Sarwath","sequence":"additional","affiliation":[{"name":"Department of Medicine, Deccan College of Medical Sciences, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"D\u2019Moss","sequence":"additional","affiliation":[{"name":"Gitam Institute of Medical Sciences and Research, Visakhapatnam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnaveni","family":"Namala","sequence":"additional","affiliation":[{"name":"Gitam Institute of Medical Sciences and Research, Visakhapatnam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneeza","family":"Zehra","sequence":"additional","affiliation":[{"name":"Department of Medicine, Karachi Medical and Dental College, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Faizan","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jinnah Postgraduate Medical Center, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Sibtain","family":"Zulfiqar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Services Institute of Medical Sciences, Services Hospital, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7195-2010","authenticated-orcid":false,"given":"Samim","family":"Noori","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, Nangarhar University, Nangarhar, Afghanistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sardar Noman","family":"Qayyum","sequence":"additional","affiliation":[{"name":"Bacha Khan Medical College, Mardan, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"R1-20260319","doi-asserted-by":"crossref","first-page":"1293\u2013300","DOI":"10.1038\/nature08933","article-title":"Genetics, pathogenesis and clinical interventions in type 1 diabetes","volume":"464","author":"Bluestone","year":"2010","journal-title":"Nature"},{"key":"R2-20260319","first-page":"69\u201382","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet Lond Engl"},{"key":"R3-20260319","doi-asserted-by":"crossref","first-page":"1676\u201385","DOI":"10.1056\/NEJM199306103282306","article-title":"Long-term complications of diabetes mellitus","volume":"328","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"R4-20260319","doi-asserted-by":"crossref","first-page":"112277","DOI":"10.1016\/j.diabres.2025.112277","article-title":"Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: results from the international diabetes federation atlas, 11th edition, and the T1DM index version 3.0","volume":"225","author":"Ogle","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"R5-20260319","doi-asserted-by":"crossref","first-page":"963\u201370","DOI":"10.2337\/dc17-1962","article-title":"Global economic burden of diabetes in adults: projections from 2015 to 2030","volume":"41","author":"Bommer","year":"2018","journal-title":"Diabetes Care"},{"key":"R6-20260319","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/2230-973X.176456","article-title":"Insulin delivery methods: past, present and future","volume":"6","author":"Shah","year":"2016","journal-title":"Int J Pharm Investig"},{"key":"R7-20260319","doi-asserted-by":"crossref","first-page":"102\u201323","DOI":"10.1111\/nyas.12431","article-title":"The artificial pancreas: current status and future prospects in the management of diabetes","volume":"1311","author":"Peyser","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"R8-20260319","doi-asserted-by":"crossref","first-page":"6989453","DOI":"10.1155\/2016\/6989453","article-title":"Complications of diabetes 2016","volume":"2016","author":"Papatheodorou","year":"2016","journal-title":"J Diabetes Res"},{"key":"R9-20260319","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13287-019-1165-5","article-title":"Stem cells: past, present, and future","volume":"10","author":"Zakrzewski","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"R10-20260319","first-page":"2472\u201383","article-title":"How to make a functional \u03b2-cell","volume":"140","author":"Pagliuca","year":"2013","journal-title":"Dev Camb Engl"},{"key":"R11-20260319","doi-asserted-by":"crossref","first-page":"1389134","DOI":"10.3389\/fimmu.2024.1389134","article-title":"Advancing diabetes treatment: the role of mesenchymal stem cells in islet transplantation","volume":"15","author":"Mou","year":"2024","journal-title":"Front Immunol"},{"key":"R12-20260319","doi-asserted-by":"crossref","first-page":"268\u201377","DOI":"10.1038\/nrendo.2016.178","article-title":"Clinical pancreatic islet transplantation","volume":"13","author":"Shapiro","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"R13-20260319","doi-asserted-by":"crossref","DOI":"10.70389\/PJS.100082","article-title":"Transparency in the reporting of Artificial INtelligence \u2013 the TITAN guideline","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R14-20260319","doi-asserted-by":"crossref","first-page":"219\u201326","DOI":"10.1038\/nrendo.2009.21","article-title":"The role of inflammation in insulitis and beta-cell loss in type 1 diabetes","volume":"5","author":"Eizirik","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"R15-20260319","doi-asserted-by":"crossref","first-page":"2753\u201386","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"R16-20260319","doi-asserted-by":"crossref","first-page":"59\u201363","DOI":"10.5966\/sctm.2011-0017","article-title":"Concise review: mesenchymal stem cells for diabetes","volume":"1","author":"Dom\u00ednguez-Bendala","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"R17-20260319","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1741-7015-10-3","article-title":"Reversal of type 1 diabetes via islet \u03b2 cell regeneration following immune modulation by cord blood-derived multipotent stem cells","volume":"10","author":"Zhao","year":"2012","journal-title":"BMC Med"},{"key":"R18-20260319","doi-asserted-by":"crossref","first-page":"428\u201339","DOI":"10.1016\/j.cell.2014.09.040","article-title":"Generation of functional human pancreatic \u03b2 cells in vitro","volume":"159","author":"Pagliuca","year":"2014","journal-title":"Cell"},{"key":"R19-20260319","doi-asserted-by":"crossref","first-page":"1121\u201333","DOI":"10.1038\/nbt.3033","article-title":"Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells","volume":"32","author":"Rezania","year":"2014","journal-title":"Nat Biotechnol"},{"key":"R20-20260319","doi-asserted-by":"crossref","first-page":"11\u201322","DOI":"10.1016\/j.stem.2015.06.007","article-title":"Stem cell therapies in clinical trials: progress and challenges","volume":"17","author":"Trounson","year":"2015","journal-title":"Cell Stem Cell"},{"key":"R21-20260319","doi-asserted-by":"crossref","first-page":"663\u201376","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"R22-20260319","doi-asserted-by":"crossref","first-page":"1\u20135","DOI":"10.4061\/2010\/582382","article-title":"Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: a novel therapy for insulin-dependent diabetes mellitus","volume":"2010","author":"Vanikar","year":"2010","journal-title":"Stem Cells Int"},{"key":"R23-20260319","first-page":"861\u201371","article-title":"Stage-specific signaling through TGF\u03b2 family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells","volume":"138","author":"Nostro","year":"2011","journal-title":"Dev Camb Engl"},{"key":"R24-20260319","doi-asserted-by":"crossref","first-page":"351\u201365","DOI":"10.1016\/j.stemcr.2018.12.012","article-title":"Acquisition of dynamic function in human stem cell-derived \u03b2 cells","volume":"12","author":"Velazco-Cruz","year":"2019","journal-title":"Stem Cell Rep"},{"key":"R25-20260319","first-page":"1392\u2013401","article-title":"Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells","volume":"24","author":"D\u2019Amour","year":"2006","journal-title":"Nat Biotechnol"},{"key":"R26-20260319","first-page":"306\u201311","article-title":"Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice","volume":"22","author":"Vegas","year":"2016","journal-title":"Nat Med"},{"key":"R27-20260319","doi-asserted-by":"crossref","first-page":"2558\u201368","DOI":"10.2337\/db10-0136","article-title":"Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates","volume":"59","author":"Berman","year":"2010","journal-title":"Diabetes"},{"key":"R28-20260319","doi-asserted-by":"crossref","first-page":"100466","DOI":"10.1016\/j.xcrm.2021.100466","article-title":"Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device","volume":"2","author":"Shapiro","year":"2021","journal-title":"Cell Rep Med"},{"key":"R29-20260319","doi-asserted-by":"crossref","first-page":"1656\u201364","DOI":"10.2337\/db12-1258","article-title":"Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes","volume":"62","author":"Piemonti","year":"2013","journal-title":"Diabetes"},{"key":"R30-20260319","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13287-020-01793-6","article-title":"Current progress in stem cell therapy for type 1 diabetes mellitus","volume":"11","author":"Chen","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"R31-20260319","doi-asserted-by":"crossref","first-page":"14\u201330","DOI":"10.1038\/s41574-024-01029-0","article-title":"Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead","volume":"21","author":"Grattoni","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"R32-20260319","doi-asserted-by":"crossref","first-page":"587\u201392","DOI":"10.2337\/db14-0656","article-title":"Preserved \u03b2-cell function in type 1 diabetes by mesenchymal stromal cells","volume":"64","author":"Carlsson","year":"2015","journal-title":"Diabetes"},{"key":"R33-20260319","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13098-017-0233-1","article-title":"Mesenchymal stem cell therapy in type 2 diabetes mellitus","volume":"9","author":"Zang","year":"2017","journal-title":"Diabetol Metab Syndr"},{"key":"R35-20260319","first-page":"337\u201340","article-title":"Donislecel: first cellular therapy to treat patients with brittle type 1 diabetes","volume":"42","author":"Giri","year":"2024","journal-title":"Clin Diabetes Publ Am Diabetes Assoc"},{"key":"R36-20260319","doi-asserted-by":"crossref","first-page":"271\u201372","DOI":"10.1038\/d41586-024-03129-3","article-title":"Stem cells reverse woman\u2019s diabetes - a world first","volume":"634","author":"Mallapaty","year":"2024","journal-title":"Nature"},{"key":"R37-20260319","doi-asserted-by":"crossref","first-page":"858\u201368","DOI":"10.1056\/NEJMoa2506549","article-title":"Stem cell-derived, fully differentiated islets for type 1 diabetes","volume":"393","author":"Reichman","year":"2025","journal-title":"N Engl J Med"},{"key":"R38-20260319","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12967-024-06019-4","article-title":"From bench to bedside: future prospects in stem cell therapy for diabetes","volume":"23","author":"Lu","year":"2025","journal-title":"J Transl Med"},{"key":"R39-20260319","doi-asserted-by":"crossref","first-page":"443\u201352","DOI":"10.1038\/nbt1393","article-title":"Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo","volume":"26","author":"Kroon","year":"2008","journal-title":"Nat Biotechnol"},{"key":"R40-20260319","doi-asserted-by":"crossref","first-page":"606\u201311","DOI":"10.1038\/s41586-020-2631-z","article-title":"Immune-evasive human islet-like organoids ameliorate diabetes","volume":"586","author":"Yoshihara","year":"2020","journal-title":"Nature"},{"key":"R41-20260319","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s13287-022-02977-y","article-title":"Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges","volume":"13","author":"Silva","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"R42-20260319","doi-asserted-by":"crossref","first-page":"114481","DOI":"10.1016\/j.addr.2022.114481","article-title":"Type 1 diabetes and engineering enhanced islet transplantation","volume":"189","author":"Jeyagaran","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"R43-20260319","first-page":"1111\u201321","article-title":"CRISPR\/Cas9 editing of induced pluripotent stem cells for engineering inflammation-resistant tissues","volume":"69","author":"Brunger","year":"2017","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"R44-20260319","doi-asserted-by":"crossref","first-page":"204\u201313","DOI":"10.1210\/er.2008-0031","article-title":"Ethical issues in stem cell research","volume":"30","author":"Lo","year":"2009","journal-title":"Endocr Rev"},{"key":"R45-20260319","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/scrt483","article-title":"Viability of equine mesenchymal stem cells during transport and implantation","volume":"5","author":"Garvican","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"R46-20260319","doi-asserted-by":"crossref","first-page":"776\u201377","DOI":"10.1126\/science.aaf4620","article-title":"Confronting stem cell hype","volume":"352","author":"Caulfield","year":"2016","journal-title":"Science"},{"key":"R47-20260319","doi-asserted-by":"crossref","first-page":"139\u201341","DOI":"10.1016\/j.stem.2010.07.004","article-title":"Getting to the heart of the matter: direct reprogramming to cardiomyocytes","volume":"7","author":"Passier","year":"2010","journal-title":"Cell Stem Cell"},{"key":"R48-20260319","doi-asserted-by":"crossref","first-page":"787\u201397","DOI":"10.1016\/j.stemcr.2016.05.001","article-title":"Setting global standards for stem cell research and clinical translation: the 2016 ISSCR guidelines","volume":"6","author":"Daley","year":"2016","journal-title":"Stem Cell Rep"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000004147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:04:36Z","timestamp":1773936276000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000004147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000004147","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"2025-04-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}